News

Press Releases

Coverage

Exploit Opportunities Offered by UDI Initiative

Sep. 24 saw the first UDI compliance deadline which means that organizations should now be focusing on the implementation phase, following a thorough preparation phase reviewing all current processes and systems in place.

Survey reveals 40% of medical device companies do not have a solution in place for labeling and packaging issues

A recent survey of medical companies in Europe and North America has identified some of the key issues for packaging and labeling operations in the complex and changing medical device market.

Label Defects Top List of Packaging Concerns for Med Devices

A survey, carried out by PRISYM ID, a leading provider of global label lifecycle management solutions for the medical device and life sciences industries, identified label defect control as one of the top issues currently facing almost 40% of medical device and pharmaceutical companies.

Survey: UDI Compliance Poses Significant Challenge

A recent survey of medical companies in Europe and North America has identified some of the key issues for packaging and labeling operations in the complex and changing medical device market.

Medical Design Technology - Ramifications of UDI Requirements

The phased introduction of Unique Device Identification (UDI) requirements in the US means that the labeling of medical devices faces unprecedented scrutiny – with ramifications not only for manufacturers but also throughout the entire supply chain.          

Medical Device and Diagnostic Industry > Label Lifecycle Management

Warren Ward-Stacey comments on how proactive medical device companies are taking a more strategic approach to the management of data by implementing fully integrated, end-to-end label life cycle management systems that capture, store, and disseminate data safely, quickly, and accurately.        

EPM - Talking Point

EPM - Talking Point

Dave Taylor discusses how clinical trial and pharmaceutical manufacturers could perhaps do more to mitigate the risks associated with the local language labeling of clinical trial supplies. If companies are to optimize emerging markets, they must adopt a more uniform approach.          

Medical Design Technology - The War On Error

Product recalls in the medical devices industry are increasing – bringing a trail of destruction to companies’ operational efficiencies and profitability. Labeling error remains a common cause of recall – but it’s one that can easily be avoided. PRISYM ID’s Craig Jones, VP Global Supports Services, outlines how vision systems can help companies eradicate costly and unnecessary labeling defects – and win the War on Error.

EMDT Online - Increasing Operational Efficiency in the Face of UDI: Taking a 360-Degree View

By Warren Ward-Stacey, SVP of Global Sales, PRISYM ID. Increasing operational efficiency whilst ensuring regulatory compliance is a primary aim for all medical device manufacturers and is a driver for change in many organizations. And whilst the last few years have seen some companies recognize the commercial benefits of introducing scalable technology solutions, others remain on the lower rungs of the evolutionary ladder. .        

feed-image Feed Entries